Formula Growth’s NeoGenomics NEO Stock Holding History

Formula Growth’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-199,100	Closed	-$3.22M	–	132
2023 Q4	$3.22M	Sell	199,100 -9,785	-5%	-$160K	1.03%	37
2023 Q3	$2.57M	Sell	208,885 -1,805	-0.9%	-$26.8K	0.88%	46
2023 Q2	$3.39M	Sell	210,690 -70,000	-25%	-$1.15M	1.08%	30
2023 Q1	$4.89M	Buy	280,690 +100,390	+56%	+$1.43M	1.57%	11
2022 Q4	$1.67M	Sell	180,300 -90,000	-33%	-$839K	0.47%	76
2022 Q3	$2.33M	Buy	270,300 +217,000	+407%	+$2.15M	0.66%	65
2022 Q2	$434K	Sell	53,300 -10,000	-16%	-$95.5K	0.12%	121
2022 Q1	$769K	Hold	63,300	–	–	0.15%	128
2021 Q4	$2.16M	Sell	63,300 -16,700	-21%	-$654K	0.38%	82
2021 Q3	$3.86M	Hold	80,000	–	–	0.55%	60
2021 Q2	$3.61M	Hold	80,000	–	–	0.5%	65
2021 Q1	$3.86M	Hold	80,000	–	–	0.56%	58
2020 Q4	$4.31M	Sell	80,000 -10,000	-11%	-$452K	0.72%	35
2020 Q3	$3.32M	Sell	90,000 -5,000	-5%	-$186K	0.62%	46
2020 Q2	$2.94M	Hold	95,000	–	–	0.5%	57
2020 Q1	$2.62M	Sell	95,000 -5,000	-5%	-$150K	0.5%	54
2019 Q4	$2.92M	Hold	100,000	–	–	0.37%	72
2019 Q3	$1.91M	Hold	100,000	–	–	0.29%	83
2019 Q2	$2.19M	Buy	+100,000	New	+$2.19M	0.31%	78

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Formula Growth's NEO Position: Q1 2024 in Review

Formula Growth sold out of NeoGenomics (NEO) in Q1 2024, closing a stake of 199,100 shares — an estimated $3.22M sold.

Formula Growth first reported a position in NEO in Q2 2019 and held it in 19 quarters. The position peaked at $4.89M in Q1 2023. 263 funds tracked by Wall St. Rank hold NEO as of Q1 2024.

Formula Growth reported no remaining NeoGenomics position as of Q1 2024 after selling out during the quarter.
Formula Growth sold 199,100 NeoGenomics shares in Q1 2024, an estimated $3.22M.
Formula Growth first reported a position in NeoGenomics in Q2 2019 and held it in 19 quarters.
Formula Growth's NeoGenomics position peaked at $4.89M in Q1 2023.
263 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2024.

Based on Formula Growth's 13F filing for Q1 2024, filed 14 May 2024.